Bellevue WA, USA, February 7th, 2019 – At the SCMR 2019 Meeting in Bellevue, Washington, which brings together top clinicians and researchers within the cardiovascular and MRI communities, Circle Cardiovascular Imaging Inc. (“Circle”), and Galgo Medical (“Galgo”), announced an agreement for distribution and joint development with respect to MRI scanner application products and workflows, with corresponding postprocessing capabilities. The focus will be to improve cardiac magnetic resonance (MR) imaging workflows and diagnostic tools, to expand accessibility and use of Cardiac MR to electrophysiology procedures such as atrial fibrillation and ventricular tachycardia ablations. As current global leaders in Cardiac MRI reading and reporting solutions, this joint agreement will further expand Circle’s innovative technology and product offerings.

“This agreement is transformational for Circle,” commented Greg Ogrodnick, President and Chief Executive Officer. "Advanced Cardiac Imaging including both Cardiac MR and Cardiac CT continues to expand its role in the diagnosis and management of patients with cardiac arrhythmias, so Circle is very excited to be able to work with Galgo on the development and commercialization of the ADAS 3D software platform. Galgo established itself as an early innovator in this field and through this partnership, Circle will bring the power of its organization and customer base to make the ADAS 3D software more widely available to the global electrophysiology community. From day one, this transaction is accretive to the company, and strengthens our leadership position in cardiac imaging globally, and in the emerging market for ablation planning in atrial fibrillation and ventricular tachycardia procedures."

“To be partnering with Circle Cardiovascular Imaging is an exciting opportunity for Galgo that we believe will impact the future of the field of Electrophysiology. Given our ability to translate MRI and CT images for the clinical use of electrophysiologists and the market leadership, and continuous drive for innovation of Circle in the field of cardiac MR, we will push to improve the treatment of atrial fibrillation and ventricular tachycardia ablation procedures for the benefit of health care professionals and their patients” said Luis Serra, President of Galgo Medical.


About Circle Cardiovascular Imaging Inc.
Circle Cardiovascular Imaging Inc. develops world class, advanced, post-processing solutions for the cardiac imaging industry. Circle is a prominent company for the global cardiac imaging community bringing together an experienced and qualified team of more than 150 people.

Circle’s imaging platform, cvi42 is the leading best-in-class cardiovascular imaging reading and reporting solution for Cardiac MR, Cardiac CT, and Cardiac Interventional Planning. Annually, hundreds of thousands of cardiac exams, in over 1000 hospitals and 40 different countries are interpreted using cvi42; it provides physicians the tools to accurately quantify and diagnose complex cardiovascular diseases while improving patient outcomes and the effective utilization of healthcare resources. Currently at version 5.10, cvi42 utilizes machine learning and big data, with the machine results demonstrating capabilities within the same range as expert human readers. Improving cardiovascular health through excellence in imaging as an integral part of precision medicine.


About Galgo Medical
Galgo Medical SL is a Barcelona-based company that emerged from the Department of Information Technologies (DTIC) at the Universitat Pompeu Fabra (Barcelona, Spain). It was incorporated in July 2013.

The team developed a solid experience in developing imaging post-processing software solutions obtained during more than seven years working together at the Universitat Pompeu Fabra. They were involved in national and international competitive projects and nurtured over the years close collaborations with several clinical institutions.

ADAS 3D is a family of products for electrophysiologists intended for the identification of arrhythmia substrate and the planning of ablation procedures using cardiac MRI and CT. The increasing availability of high-quality patient images enables ADAS 3D algorithms to extract key clinical information to support clinical decisionmaking, planning, and guidance of such EP ablative procedures. ADAS 3D has received CE mark approval in Europe.